STOCK TITAN

4Front Ventures Announces Issuance of Warrants Under Consulting Services Agreement

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
4Front Ventures Corp. intends to issue 750,000 share purchase warrants to a consultant. Each warrant can be exercised at C$0.14 into one class A subordinate voting share for 4 years.
Positive
  • None.
Negative
  • None.

PHOENIX, Aug. 18, 2023 /PRNewswire/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company") announced today that it intends to issue 750,000 share purchase warrants to an arm's-length consultant under a consulting services agreement. Each warrant will be exercisable at C$0.14 into one class A subordinate voting share of the Company for a period of 4 years. In accordance with the policies of the Canadian Securities Exchange, the issuance of warrants will not occur prior to five business days from the date of this announcement.

About 4Front Ventures Corp.

4Front is a national, vertically integrated multi-state cannabis operator who owns or manages operations and facilities in strategic medical and adult-use cannabis markets, including California, Illinois, Massachusetts, Michigan, and Washington. Since its founding in 2011, 4Front has built a strong reputation for its high standards and low-cost cultivation and production methodologies earned through a track record of success in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. To date, 4Front has successfully brought to market more than 20 different cannabis brands and over 1800 products, which are strategically distributed through its fully owned and operated Mission dispensaries and retail outlets in its core markets. As the Company continues to drive value for its shareholders, its team is applying its decade of expertise in the sector across the cannabis industry value chain and ecosystem. For more information, visit https://4frontventures.com/.

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this press release may be considered forward-looking, such as statements regarding the issuance of the Warrants and the Company's potential to drive value for its shareholders. Forward-looking statements are typically identified by words and phrases such as "anticipate," "estimate," "believe," "continue," "could," "intend," "may," "plan," "potential," "predict," "seek," "should," "will," "would," "expect," "objective," "projection," "forecast," "goal," "guidance," "outlook," "effort," "target" or the negative of such words and other comparable terminology. However, the absence of these words does not mean that a statement is not forward-looking. Any forward-looking statements expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and involve risks, uncertainties and other factors beyond 4Front's control. Therefore, you are cautioned against relying on any of these forward-looking statements. Actual outcomes and results may differ materially from what is expressed in any forward-looking statement. Except as required by applicable law, including Canadian and U.S. federal securities laws, 4Front does not intend to update any of the forward-looking statements to conform them to actual results or revised expectations.

Cision View original content:https://www.prnewswire.com/news-releases/4front-ventures-announces-issuance-of-warrants-under-consulting-services-agreement-301904798.html

SOURCE 4Front Ventures Corp.

4FRONT VENTURES CORP

OTC:FFNTF

FFNTF Rankings

FFNTF Latest News

FFNTF Stock Data

29.25M
447.79M
51%
6.78%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Phoenix